Cadrenal Therapeutics Inc. Insider Trading
CVKD
Insiders sold 458K and bought nothing on the open market.
All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Oct 2023.
Get an email when CVKD's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29 | Quang X Pham Chairman and CEO | Sold10b5-1 plan | 7,400 | $3.03 | 22K | 2.4% | Form 4 |
| Jun 25 – 26 | Quang X Pham Chairman, CEO and Interim CFO | Sold10b5-1 plan 2 parts | 11,156 | $3.04 average | 34K | 3.5% | Form 4 |
| Jun 22 – 23 | Quang X Pham Chairman, CEO and Interim CFO | Sold10b5-1 plan 2 parts | 11,444 | $3.48 average | 40K | 3.5% | Form 4 |
| Jun 16 – 17 | Quang X Pham Chairman, CEO and Interim CFO | Sold10b5-1 plan 2 parts | 4,126 | $3.18 average | 13K | 1.2% | Form 4 |
| Jun 11 – 15 | Quang X Pham Chairman, CEO and Interim CFO | Sold10b5-1 plan 3 parts | 18,124 | $3.88 average | 70K | 5.2% | Form 4 |
| Jun 8 – 10 | Quang X Pham Chairman, CEO and Interim CFO | Sold10b5-1 plan 3 parts | 22,385 | $4.17 average | 93K | 6.0% | Form 4 |
| Jun 3 – 5 | Quang X Pham CEO and Chairman | Sold10b5-1 plan 3 parts | 8,285 | $4.37 average | 36K | 2.2% | Form 4 |
| May 29 – Jun 2 | Quang X Pham CEO and Chairman | Sold10b5-1 plan 2 parts | 652 | $4.72 average | 3K | 0.2% | Form 4 |
| May 11 – 28 | Quang X Pham CEO and Chairman | Sold10b5-1 plan 3 parts | 12,763 | $5.44 average | 69K | 3.2% | Form 4 |
| May 22 | Quang X Pham CEO and Chairman | Sold10b5-1 plan | 1,165 | $5.69 | 7K | 0.5% | Form 4 |
| Dec 29, 2025 | Matthew K Szot Chief Financial Officer | Sold10b5-1 plan | 9,933 | $6.97 | 69K | 100% | Form 4 |
| Oct 24, 2025 – Oct 27, 2025 | Matthew K Szot Chief Financial Officer | Sold10b5-1 plan 2 parts | 3,600 | $13.99 average | 50K | 27% | Form 4 |
| Oct 24, 2025 – Oct 27, 2025 | Quang X Pham CEO and Chairman | Sold10b5-1 plan 2 parts | 2,444 | $14.01 average | 34K | 0.6% | Form 4 |
| Oct 9, 2025 – Oct 13, 2025 | Quang X Pham CEO and Chairman | Sold10b5-1 plan 2 parts | 3,600 | $14.09 average | 51K | 0.9% | Form 4 |
| Oct 9, 2025 – Oct 13, 2025 | Matthew K Szot Chief Financial Officer | Sold10b5-1 plan 2 parts | 3,493 | $14.03 average | 49K | 21% | Form 4 |
| Oct 6, 2025 | Matthew K Szot Chief Financial Officer | Sold10b5-1 plan | 107 | $13.99 | 1K | 0.6% | Form 4 |
| Oct 2, 2025 | Quang X Pham CEO and Chairman | Sold10b5-1 plan | 500 | $14.13 | 7K | 0.1% | Form 4 |
| Sep 29, 2025 – Oct 1, 2025 | Matthew K Szot Chief Financial Officer | Sold10b5-1 plan 2 parts | 1,800 | $13.99 average | 25K | 9.5% | Form 4 |
| Sep 29, 2025 – Oct 1, 2025 | Quang X Pham CEO and Chairman | Sold10b5-1 plan 2 parts | 1,300 | $14.01 average | 18K | 0.3% | Form 4 |
| Sep 24, 2025 – Sep 25, 2025 | Matthew K Szot Chief Financial Officer | Sold10b5-1 plan 2 parts | 12,400 | $14.04 average | 174K | 40% | Form 4 |
| Sep 24, 2025 – Sep 25, 2025 | Quang X Pham CEO and Chairman | Sold10b5-1 plan 2 parts | 9,371 | $14.06 average | 132K | 2.3% | Form 4 |
| Aug 27, 2025 – Aug 28, 2025 | Matthew K Szot Chief Financial Officer | Sold10b5-1 plan 2 parts | 2,000 | $14.00 average | 28K | 6.0% | Form 4 |
| Aug 27, 2025 – Aug 28, 2025 | Quang X Pham CEO and Chairman | Sold10b5-1 plan 2 parts | 5,029 | $13.99 average | 70K | 1.2% | Form 4 |
- Jun 2910b5-1 planQuang X PhamChairman and CEO · sold 7,400 at $3.0322K2.4% of stake
- Jun 25 – 2610b5-1 planQuang X PhamChairman, CEO and Interim CFO · sold 11,156 at avg $3.0434K3.5% of stake
- Jun 22 – 2310b5-1 planQuang X PhamChairman, CEO and Interim CFO · sold 11,444 at avg $3.4840K3.5% of stake
- Jun 16 – 1710b5-1 planQuang X PhamChairman, CEO and Interim CFO · sold 4,126 at avg $3.1813K1.2% of stake
- Jun 11 – 1510b5-1 planQuang X PhamChairman, CEO and Interim CFO · sold 18,124 at avg $3.8870K5.2% of stake
- Jun 8 – 1010b5-1 planQuang X PhamChairman, CEO and Interim CFO · sold 22,385 at avg $4.1793K6.0% of stake
- Jun 3 – 510b5-1 planQuang X PhamCEO and Chairman · sold 8,285 at avg $4.3736K2.2% of stake
- May 29 – Jun 210b5-1 planQuang X PhamCEO and Chairman · sold 652 at avg $4.723K0.2% of stake
- May 11 – 2810b5-1 planQuang X PhamCEO and Chairman · sold 12,763 at avg $5.4469K3.2% of stake
- May 2210b5-1 planQuang X PhamCEO and Chairman · sold 1,165 at $5.697K0.5% of stake
- Dec 29, 202510b5-1 planMatthew K SzotChief Financial Officer · sold 9,933 at $6.9769K100% of stake
- Oct 24, 2025 – Oct 27, 202510b5-1 planMatthew K SzotChief Financial Officer · sold 3,600 at avg $13.9950K27% of stake
- Oct 24, 2025 – Oct 27, 202510b5-1 planQuang X PhamCEO and Chairman · sold 2,444 at avg $14.0134K0.6% of stake
- Oct 9, 2025 – Oct 13, 202510b5-1 planQuang X PhamCEO and Chairman · sold 3,600 at avg $14.0951K0.9% of stake
- Oct 9, 2025 – Oct 13, 202510b5-1 planMatthew K SzotChief Financial Officer · sold 3,493 at avg $14.0349K21% of stake
- Oct 6, 202510b5-1 planMatthew K SzotChief Financial Officer · sold 107 at $13.991K0.6% of stake
- Oct 2, 202510b5-1 planQuang X PhamCEO and Chairman · sold 500 at $14.137K0.1% of stake
- Sep 29, 2025 – Oct 1, 202510b5-1 planMatthew K SzotChief Financial Officer · sold 1,800 at avg $13.9925K9.5% of stake
- Sep 29, 2025 – Oct 1, 202510b5-1 planQuang X PhamCEO and Chairman · sold 1,300 at avg $14.0118K0.3% of stake
- Sep 24, 2025 – Sep 25, 202510b5-1 planMatthew K SzotChief Financial Officer · sold 12,400 at avg $14.04174K40% of stake
- Sep 24, 2025 – Sep 25, 202510b5-1 planQuang X PhamCEO and Chairman · sold 9,371 at avg $14.06132K2.3% of stake
- Aug 27, 2025 – Aug 28, 202510b5-1 planMatthew K SzotChief Financial Officer · sold 2,000 at avg $14.0028K6.0% of stake
- Aug 27, 2025 – Aug 28, 202510b5-1 planQuang X PhamCEO and Chairman · sold 5,029 at avg $13.9970K1.2% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with CVKD
Spot a number that looks wrong? Check it in CVKD's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CVKD
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.